Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00900562
What this trial is testing

Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy

Who this might be right for
Uterine Cervical CancerEndometrial Cancer
PharmaMar 19
Not applicableStudy completedNCT04603599
What this trial is testing

Relationship of Endometrial Cancer and Serum Soluble L1CAM Level

Who this might be right for
Endometrium Cancer
Kocaeli University 146
Testing effectiveness (Phase 2)Study completedNCT01367002
What this trial is testing

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Who this might be right for
Endometrial Cancer
Yale University 61
Not applicableStudy completedNCT02003430
What this trial is testing

Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers

Who this might be right for
Non-ovarian Gynecological Cancers
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)WithdrawnNCT02042495
What this trial is testing

Endometrial Cancer Biomarker Changes Following Exposure to Metformin

Who this might be right for
Endometrial Cancer
Jewish General Hospital
Large-scale testing (Phase 3)Active Not RecruitingNCT04214067
What this trial is testing

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Who this might be right for
Endometrial Endometrioid AdenocarcinomaStage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Study completedNCT04570839
What this trial is testing

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

Who this might be right for
Endometrial NeoplasmsOvarian CancerSolid Tumor+1 more
Compugen Ltd 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing

Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers

Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138
Not applicableUnknownNCT05712668
What this trial is testing

Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors

Who this might be right for
TelemedicineCounseling
Carilion Clinic 100
Large-scale testing (Phase 3)Study completedNCT00002459
What this trial is testing

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Who this might be right for
Endometrial CancerSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 224
Testing effectiveness (Phase 2)WithdrawnNCT05483023
What this trial is testing

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT04634617
What this trial is testing

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Who this might be right for
Endometrial CarcinomaMalignant Uterine NeoplasmUterine Corpus Cancer+1 more
M.D. Anderson Cancer Center 310
Early research (Phase 1)Active Not RecruitingNCT04092270
What this trial is testing

A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer

Who this might be right for
Endometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more
National Cancer Institute (NCI) 55
Not applicableActive Not RecruitingNCT04276532
What this trial is testing

Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Who this might be right for
Middle-high Risk Endometrial CancerSentinel Lymph Node SamplingPrognosis
Xiaojun Chen 780
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Not applicableNot Yet RecruitingNCT05998798
What this trial is testing

Revealing Engagement Patterns Among Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
Power Life Sciences Inc. 500
Not applicableUnknownNCT03804463
What this trial is testing

The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer

Who this might be right for
Endometrial Cancer
Min Wang 170
Early research (Phase 1)Study completedNCT01364844
What this trial is testing

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Solid TumorColorectal CancerEndometrial Cancer
Daiichi Sankyo 42
Not applicableUnknownNCT06238284
What this trial is testing

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Chongqing University Cancer Hospital 300
Not applicableUnknownNCT00299481
What this trial is testing

Tissue Bank of Biological Specimens From Patients With Gynecologic Disease

Who this might be right for
Endometrial NeoplasmsUterine Cervical NeoplasmsOvarian Neoplasms+1 more
U.S. Army Medical Research and Development Command 7,000
Next Page